194 related articles for article (PubMed ID: 30896866)
1. Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
Cheng Z; Shao X; Xu M; Wang J; Kuai X; Zhang L; Wu J; Zhou C; Mao J
Oncol Rep; 2019 May; 41(5):2717-2728. PubMed ID: 30896866
[TBL] [Abstract][Full Text] [Related]
2. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway.
Li Z; Li Y; Jia Y; Ding B; Yu J
Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637
[TBL] [Abstract][Full Text] [Related]
3. Rab1A promotes cell proliferation and migration by upregulating Gli1 in colorectal cancer.
Peng C; Li X; Ye Z; Wu W
Sci Rep; 2021 Aug; 11(1):16243. PubMed ID: 34376787
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of Rab1A and its prognostic significance in human colorectal cancer.
Wang ZK; Cheng ZW; Chen SJ; Zhu XG; Gu YP; Yang XD; Sun L; Liu WT; Zhang YJ; Yuan JF; Tian KJ; Yao YZ; He SB
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4509-4517. PubMed ID: 30058685
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells.
Xu H; Qian M; Zhao B; Wu C; Maskey N; Song H; Li D; Song J; Hua K; Fang L
Oncol Rep; 2017 Mar; 37(3):1619-1626. PubMed ID: 28184936
[TBL] [Abstract][Full Text] [Related]
6. Expression analysis and implication of Rab1A in gastrointestinal relevant tumor.
Xu M; Shao X; Kuai X; Zhang L; Zhou C; Cheng Z
Sci Rep; 2019 Sep; 9(1):13384. PubMed ID: 31527621
[TBL] [Abstract][Full Text] [Related]
7. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer.
Xu M; Shao X; Li H; Zhang Z; Zhou C; Cheng Z
Sci Rep; 2020 Nov; 10(1):20160. PubMed ID: 33214609
[TBL] [Abstract][Full Text] [Related]
8. Circ_0000218 plays a carcinogenic role in colorectal cancer progression by regulating miR-139-3p/RAB1A axis.
Pei FL; Cao MZ; Li YF
J Biochem; 2020 Jan; 167(1):55-65. PubMed ID: 31598673
[TBL] [Abstract][Full Text] [Related]
9. Rab1A is an mTORC1 activator and a colorectal oncogene.
Thomas JD; Zhang YJ; Wei YH; Cho JH; Morris LE; Wang HY; Zheng XF
Cancer Cell; 2014 Nov; 26(5):754-69. PubMed ID: 25446900
[TBL] [Abstract][Full Text] [Related]
10. Expression of Rab1A is upregulated in human lung cancer and associated with tumor size and T stage.
Wang X; Liu F; Qin X; Huang T; Huang B; Zhang Y; Jiang B
Aging (Albany NY); 2016 Nov; 8(11):2790-2798. PubMed ID: 27902464
[TBL] [Abstract][Full Text] [Related]
11. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A.
Xu BH; Li XX; Yang Y; Zhang MY; Rao HL; Wang HY; Zheng XF
Oncotarget; 2015 Aug; 6(25):20813-28. PubMed ID: 26308575
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Rab31 is associated with poor prognosis and promotes colorectal carcinoma proliferation via the mTOR/p70S6K/Cyclin D1 signalling pathway.
Yang L; Tian X; Chen X; Lin X; Tang C; Gao Y; Chen S; Ge Z
Life Sci; 2020 Sep; 257():118126. PubMed ID: 32707053
[TBL] [Abstract][Full Text] [Related]
13. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
Xu M; Wang J; Li H; Zhang Z; Cheng Z
Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of phosphorylated mammalian target of rapamycin and its downstream signaling components in invasive breast cancer.
Ma BL; Shan MH; Sun G; Ren GH; Dong C; Yao X; Zhou M
Mol Med Rep; 2015 Oct; 12(4):5246-54. PubMed ID: 26151180
[TBL] [Abstract][Full Text] [Related]
15. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
Li Q; Tang H; Hu F; Qin C
J Cell Biochem; 2019 Mar; 120(3):3853-3860. PubMed ID: 30321450
[TBL] [Abstract][Full Text] [Related]
16. The association of aberrant expression of NLRP3 and p-S6K1 in colorectal cancer.
Wang B; Li H; Wang X; Zhu X
Pathol Res Pract; 2020 Jan; 216(1):152737. PubMed ID: 31757663
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.
Qin A; Qian W
Int J Mol Med; 2018 Nov; 42(5):2503-2514. PubMed ID: 30226533
[TBL] [Abstract][Full Text] [Related]
18. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
19. Silencing of RHEB inhibits cell proliferation and promotes apoptosis in colorectal cancer cells via inhibition of the mTOR signaling pathway.
Tian Y; Shen L; Li F; Yang J; Wan X; Ouyang M
J Cell Physiol; 2020 Jan; 235(1):442-453. PubMed ID: 31332784
[TBL] [Abstract][Full Text] [Related]
20. Prognosis, Significance and Positive Correlation of Rab1A and p-S6K/Gli1 Expression in Gastric Cancer.
Shao X; Cheng Z; Xu M; Mao J; Wang J; Zhou C
Anticancer Agents Med Chem; 2019; 19(11):1359-1367. PubMed ID: 31038077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
